AXIN1遺伝子は、RGSドメイン(英語版)とDIX(dishevelled and axin)ドメインを持つ細胞質タンパク質をコードする。AXIN1タンパク質は、APC、β-カテニン、GSK3β、PP2、そして自身と相互作用する。このタンパク質はWntシグナル伝達経路の負の調節因子として機能し、アポトーシスを誘導することができる。このタンパク質の一部は、単体構造そして他のタンパク質との複合体の結晶構造が解かれている。この遺伝子の変異は、肝細胞癌、肝芽腫、類内膜腺癌、髄芽腫と関係している。この遺伝子には異なるアイソフォームをコードする複数の転写バリアントが同定されている。
↑“The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation”.Cell90(1): 181–92.(August 1997).doi:10.1016/S0092-8674(00)80324-4.PMID9230313.
123“Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level”.Genes Cells3(6): 395–403.(June 1998).doi:10.1046/j.1365-2443.1998.00198.x.PMID9734785.
123“Casein kinase I and casein kinase II differentially regulate axin function in Wnt and JNK pathways”.J. Biol. Chem.277(20): 17706–12.(May 2002).doi:10.1074/jbc.M111982200.PMID11884395.
↑“Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway”.Mol. Cell7(4): 801–9.(April 2001).doi:10.1016/S1097-2765(01)00224-6.PMID11336703.
↑“Dimerization choices control the ability of axin and dishevelled to activate c-Jun N-terminal kinase/stress-activated protein kinase”.J. Biol. Chem.275(32): 25008–14.(August 2000).doi:10.1074/jbc.M002491200.PMID10829020.
↑“Inhibition of the Wnt signaling pathway by the PR61 subunit of protein phosphatase 2A”.J. Biol. Chem.276(29): 26875–82.(July 2001).doi:10.1074/jbc.M100443200.PMID11297546.
↑Spit,Maureen;Fenderico,Nicola;Jordens,Ingrid;Radaszkiewicz,Tomasz;Lindeboom,Rik GH;Bugter,Jeroen M;Cristobal,Alba;Ootes,Larset al.(15 September 2020).“RNF 43 truncations trap CK 1 to drive niche‐independent self‐renewal in cancer”.The EMBO Journal39(18).doi:10.15252/embj.2019103932.PMID32965059.
“The relationship between chromosome structure and function at a human telomeric region”.Nat. Genet.15(3): 252–7.(1997).doi:10.1038/ng0397-252.PMID9054936.
“Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta”.Curr. Biol.8(10): 573–81.(1998).doi:10.1016/S0960-9822(98)70226-X.PMID9601641.
“Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level”.Genes Cells3(6): 395–403.(1998).doi:10.1046/j.1365-2443.1998.00198.x.PMID9734785.
“Identification of a domain of Axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain”.J. Biol. Chem.274(6): 3439–45.(1999).doi:10.1074/jbc.274.6.3439.PMID9920888.
“A GSK3beta phosphorylation site in axin modulates interaction with beta-catenin and Tcf-mediated gene expression”.Biochem. Biophys. Res. Commun.266(1): 28–35.(2000).doi:10.1006/bbrc.1999.1760.PMID10581160.
“GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin”.Oncogene19(4): 537–45.(2000).doi:10.1038/sj.onc.1203359.PMID10698523.
“AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1”.Nat. Genet.24(3): 245–50.(2000).doi:10.1038/73448.PMID10700176.
“Dimerization choices control the ability of axin and dishevelled to activate c-Jun N-terminal kinase/stress-activated protein kinase”.J. Biol. Chem.275(32): 25008–14.(2000).doi:10.1074/jbc.M002491200.PMID10829020.
“Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16”.Hum. Mol. Genet.10(4): 339–52.(2001).doi:10.1093/hmg/10.4.339.PMID11157797.
“Inhibition of the Wnt signaling pathway by the PR61 subunit of protein phosphatase 2A”.J. Biol. Chem.276(29): 26875–82.(2001).doi:10.1074/jbc.M100443200.PMID11297546.
“Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway”.Mol. Cell7(4): 801–9.(2001).doi:10.1016/S1097-2765(01)00224-6.PMID11336703.
“Axin-dependent phosphorylation of the adenomatous polyposis coli protein mediated by casein kinase 1epsilon”.J. Biol. Chem.276(42): 39037–45.(2001).doi:10.1074/jbc.M105148200.PMID11487578.